Ingevity Corporation logo

Ingevity Corporation (NGVT)

Market Closed
3 Jun, 20:00
NYSE NYSE
$
66. 97
-0.2
-0.3%
$
2.38B Market Cap
- P/E Ratio
- Div Yield
146,319 Volume
3.6 Eps
$ 67.17
Previous Close
Add Transaction
Day Range
66.63 67.74
Year Range
39.74 79.29
Want to track NGVT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Ingevity Q2 Earnings Surpass Estimates, Revenues Decline Y/Y

Ingevity Q2 Earnings Surpass Estimates, Revenues Decline Y/Y

NGVT posts higher second-quarter adjusted earnings despite revenue drop, lifts 2025 outlook on stronger auto production forecasts.

Zacks | 9 months ago
Ingevity Corporation (NGVT) Q2 2025 Earnings Call Transcript

Ingevity Corporation (NGVT) Q2 2025 Earnings Call Transcript

Ingevity Corporation (NYSE:NGVT ) Q2 2025 Earnings Conference Call August 5, 2025 10:00 AM ET Company Participants David H. Li - President, CEO & Director John E.

Seekingalpha | 10 months ago
Why Is Ingevity (NGVT) Up 6.4% Since Last Earnings Report?

Why Is Ingevity (NGVT) Up 6.4% Since Last Earnings Report?

Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock?

Zacks | 0 year ago
Ingevity Q1 Earnings Up, Revenues Down Y/Y on Repositioning Actions

Ingevity Q1 Earnings Up, Revenues Down Y/Y on Repositioning Actions

NGVT's earnings increase, but revenues are impacted by the Performance Chemical segment's repositioning measures.

Zacks | 1 year ago
Ingevity Corporation (NGVT) Q1 2025 Earnings Call Transcript

Ingevity Corporation (NGVT) Q1 2025 Earnings Call Transcript

Ingevity Corporation (NYSE:NGVT ) Q1 2025 Results Conference Call May 6, 2025 9:00 AM ET Company Participants John Nypaver - Vice President, Treasurer & Investor Relations David Li - President & Chief Executive Officer Mary Dean Hall - Executive Vice President & Chief Financial Officer Conference Call Participants John McNulty - BMO Capital Markets Jon Tanwanteng - CJS Securities Daniel Rizzo - Jefferies Abigail Eberts - Wells Fargo Securities Operator Good morning or good afternoon. I welcome to the Ingevity First Quarter 2025 Earnings Call and Webcast.

Seekingalpha | 1 year ago
Here's Why You Should Add Ingevity Stock to Your Portfolio

Here's Why You Should Add Ingevity Stock to Your Portfolio

NGVT benefits from the repositioning of its Performance Chemicals segment, strategic acquisitions and actions to drive growth.

Zacks | 1 year ago
Ingevity's Shares Up 10% in 6 Months: What's Driving the Stock?

Ingevity's Shares Up 10% in 6 Months: What's Driving the Stock?

NGVT gains on the repositioning of its Performance Chemicals segment, strategic acquisitions and actions to drive growth.

Zacks | 1 year ago
Why Is Ingevity (NGVT) Down 8.3% Since Last Earnings Report?

Why Is Ingevity (NGVT) Down 8.3% Since Last Earnings Report?

Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock?

Zacks | 1 year ago
Why Ingevity (NGVT) is a Top Momentum Stock for the Long-Term

Why Ingevity (NGVT) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 1 year ago
Here's What Makes Ingevity Stock a Solid Choice Right Now

Here's What Makes Ingevity Stock a Solid Choice Right Now

NGVT benefits from the repositioning of its Performance Chemicals segment to rationalize its manufacturing footprint and strategic acquisitions.

Zacks | 1 year ago
Zacks Industry Outlook Axalta Coating, Ingevity and Flexible Solutions International

Zacks Industry Outlook Axalta Coating, Ingevity and Flexible Solutions International

Axalta Coating, Ingevity and Flexible Solutions International have been highlighted in this Industry Outlook article.

Zacks | 1 year ago
Ingevity's Q4 Earnings Beat Estimates, Revenues Down Y/Y

Ingevity's Q4 Earnings Beat Estimates, Revenues Down Y/Y

NGVT's top line declines year over year in the fourth quarter due to the repositioning of the Performance Chemicals segment.

Zacks | 1 year ago
Loading...
Load More